Biotech Stock 685% Draws Big Investment Amid FDA Filings
A biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
A strong index level often signals robust momentum and potential persistence. Interpret carefully to adjust positions and risk exposure.
24,666 articlesA biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
Cloud giants are expanding, yet the super micro computer stock slid on a capital-raise plan. This article breaks down...
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
A Life360 board director recently sold several thousand shares after exercising options, timing that coincides with a...
Choosing between NZAC screens climate and IEMG can shape your long-term goals. This guide breaks down how these funds...
A new payment option is pushing into the spotlight without fanfare. Pay-by-bank quietly gaining ground challenges the...
January 2026 brings a shift in power toward buyers. Homes stay on the market longer, and sellers are more willing to ...
When AI dominates headlines, investors often fear every software stock will crumble. This piece digs into whether fig...
SpaceX is speeding up its IPO timeline, shaking up the investing world. This guide breaks down 10 essential what-to-k...
Tesla's robotaxi venture is facing real-world hurdles in Texas. This article breaks down what those problems mean for...
A fresh AI-driven rally has investors buzzing about Alphabet. This article breaks down why alphabet stock popped toda...
June brings a wave of AI-focused optimism to fintech stocks. Nu Holdings shines as AI-powered lending gains attention...